Sept. 25, 2020 |
|
Nov. 12, 2020 |
|
jRCTs051200060 |
Evaluation of safety and efficacy of post exposure prophylaxis with hydroxychloroquine aiming at prevention of COVID-19 for medical care workers |
|
Prohylaxis with hydroxichloroquine aiming at prevention of COVID-19 for medical care workers |
Kakeya Hiroshi |
||
Osaka City University hospital |
||
1-4-3, Asahicho, Abeno, Osaka, Osaka |
||
+81-6-6645-3784 |
||
kakeya@med.osaka-cu.ac.jp |
||
Kaneko Akira |
||
University Public Corporation Osaka, Osaka City University |
||
1-4-3, Asahicho, Abeno, Osaka, Osaka |
||
+81-6-6645-3760 |
||
akira555@med.osaka-cu.ac.jp |
Sept. 25, 2020 |
||
500 | ||
Interventional |
||
non-randomized controlled trial |
||
open(masking not used) |
||
no treatment control |
||
parallel assignment |
||
prevention purpose |
||
none |
||
1) Male or female with age 18 or greater at the time of consent |
||
(1) History of COVID-19 |
||
18age old over | ||
No limit | ||
Both |
||
COVID-19 infection |
||
Hydroxychloroquine |
||
One or two tables of hydroxychloroquine sulfate 200mg once in a day, after meal, oral, for 7 days |
||
006 |
||
COVID-19 infection |
||
Serious adverse events during the drug administration period |
||
Safety |
Pending |
University Public Corporation Osaka, OsakaCity University | |
Applicable |
Osaka City University Hospital Certified Review Board | |
Abeno Medics 5F, 1-2-7, Asahicho, Abeno, Osaka, Osaka, Osaka | |
+81-6-6645-3456 |
|
irb@med.osaka-cu.ac.jp | |
Approval | |
Sept. 16, 2020 |